pK27Sumo_His-SUMO-PLpro (nsp3) (SARS-CoV-2) Citations (1)

Originally described in: Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease.
Lim CT, Tan KW, Wu M, Ulferts R, Armstrong LA, Ozono E, Drury LS, Milligan JC, Zeisner TU, Zeng J, Weissmann F, Canal B, Bineva-Todd G, Howell M, O'Reilly N, Beale R, Kulathu Y, Labib K, Diffley JFX Biochem J. 2021 Jul 16;478(13):2517-2531. doi: 10.1042/BCJ20210244. PubMed Journal

---

Articles Citing pK27Sumo_His-SUMO-PLpro (nsp3) (SARS-CoV-2)

Articles
Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections. Mani S, Kaur A, Jakhar K, Kumari G, Sonar S, Kumar A, Das S, Kumar S, Kumar V, Kundu R, Pandey AK, Singh UP, Majumdar T. Int J Biol Macromol. 2023 Aug 1;245:125444. doi: 10.1016/j.ijbiomac.2023.125444. Epub 2023 Jun 27. PubMed

If you have published an article using this material, please email us at to have your article added to this page.